Inhibition of Mitochondrial Function by Efavirenz Increases Lipid Content in Hepatic Cells

Abstract

Clinical concentrations of EFV induce bioenergetic stress in hepatic cells by acutely inhibiting mitochondrial function. This new mechanism of mitochondrial interference leads to an accumulation of lipids in the cytoplasm that is mediated by activation of AMPK.

References

Page 1

	Year	Citations
Nile red: a selective fluorescent stain for intracellular lipid droplets. Phillip Greenspan, Eugene P. Mayer, Stanley D. Fowler The Journal of Cell Biology Lipid AnalysisLipid DropletsLipid MovementCellular PhysiologyYellow-gold Fluorescence	1985	2.5K
Antiretroviral Treatment of Adult HIV Infection Paul A. Volberding JAMA	2012	2.5K
Molecular mediators of hepatic steatosis and liver injury Jeffrey D. Browning, Jay D. Horton Journal of Clinical Investigation Metabolic DisorderImmunologyPathologyFatty Liver DiseaseOxidative Stress	2004	1.8K
Antiretroviral Treatment of Adult HIV Infection Scott M. Hammer, Joseph J. Eron, Peter Reiss, JAMA	2008	1K
Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults Schlomo Staszewski, Javier O Morales-Ramirez, Karen T. Tashima, New England Journal of Medicine	1999	1K
Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients Catia Marzolini, Amalio Telenti, Laurent A. Décosterd, AIDS	2001	831
Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infections Mark Sulkowski, David L. Thomas, Shruti H. Mehta, Hepatology Hepatitis BPharmacotherapyAntiviral DrugHuman Immunodeficiency VirusAutoimmune Liver Disease	2002	521
Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes Alain Berson, Virginie de Beco, Philippe Lettéron, Gastroenterology Mitochondrial DysfunctionLipid PeroxidationFatty Liver DiseaseOxidative StressInflammation	1998	406
Prediction of Neuropsychiatric Adverse Events Associated with Long-Term Efavirenz Therapy, Using Plasma Drug Level Monitoring Félix Gutiérrez, Sergio Padilla, Raúl López‐Antón, Clinical Infectious Diseases	2005	218
Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors Ulrich A. Walker, Bernhard Setzer, Nils Venhoff AIDS	2002	214

Page 1